Navigation Links
Advocacy Group Awards $300,000 to Young Scientists in Search of a Cure for Bladder Cancer
Date:5/11/2013

Bethesda, MD (PRWEB) May 11, 2013

Just as National Cancer Research month begins, the Bladder Cancer Advocacy Network (BCAN) has announced the recipients of its Young Investigator Awards. BCAN’s Scientific Review Group, chaired by Matt Milowsky, MD at the University of North Carolina’s Lineberger Comprehensive Cancer Center, evaluated 36 applications from 29 institutions.

The BCAN Young Investigator Award was granted to David DeGraff, PhD, a Postdoctoral Fellow at Vanderbilt University Medical Center for “Transcriptional Control of Bladder Cancer Tumorigenesis.”

The Raymond and Maria Floyd Family Young Investigator Award was received by Debashis Sahoo, PhD, an Instructor at Stanford University for “High resolution molecular analysis of CD-47mediated immune escape in bladder cancer.”

The James Family Young Investigator Award was awarded to Gopa Iyer, MD, a Clinical Instructor at Memorial Sloan-Kettering Cancer Center for “Identifying Predictors of Response to mTOR-targeted Therapies in Bladder Cancer.”

“We are excited about being able to offer awards that are large enough to have a significant impact on new research being undertaken throughout the country,” says BCAN President and Co-Founder, Diane Zipursky Quale. “Research in bladder cancer is woefully underfunded, so we are incredibly grateful to our supporters for contributing private dollars to help young, innovative investigators stay in the field of bladder cancer research.”

BCAN’s new Young Investigator Awards are intended to support the development of outstanding research scientists and clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of bladder cancer. Investigators may be working in basic, translational, clinical, epidemiologic, bioengineering or any other field, but must be working in a research environment capable of supporting transformational bladder cancer research. Each Young Investigator is awarded $100,000 over a two-year period.

The program was seeded through a $250,000 challenge grant received from the Gerald C. McNamara and Renée K. Petrofes Charitable Fund encouraging outstanding young researchers to focus on bladder cancer research. BCAN responded by raising more than $500,000 in additional private funds to further develop the program. Two of the awards hold the names of prominent supporters of bladder cancer research whose families have been directly affected by the disease: the Raymond and Maria Floyd Family Young Investigator Award and the James Family Foundation Young Investigator Award.

# # #

About the Bladder Cancer Advocacy Network
The Bladder Cancer Advocacy Network (BCAN – pronounced beacon) was created in May 2005 as the first national non-profit patient-based advocacy organization for bladder cancer. BCAN’s mission is to increase public awareness about bladder cancer, advance bladder cancer research, and provide educational and support services for the bladder cancer community. BCAN is a national collaborative effort among bladder cancer survivors, their loved ones, and the medical community. For more information on BCAN, please visit the web site at http://www.bcan.org or call 888-901-BCAN.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10719623.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Advocacy toolkit launched to halt the runaway train of cancer in Africa
2. Advocacy for planned home birth not in patients best interest
3. HypothyroidMom.com Launches Thyroid Advocacy Site for Moms with Hypothyroidism
4. The Jerome Lejeune Foundation, USA Joins Advocacy Organizations Worldwide to Say: Down Syndrome - So What!
5. HypothyroidMom.com Announces Advocacy for Thyroid Testing in Mental Disorders in 2013
6. Tuscan Olive Oil Advocacy Group Flavor Your Life Sheds Light on Olive Oil History
7. 30 Years of Orphan Drug Act, Combined with Science and Advocacy, Reflect Dramatic Progress in a Rare Lung Disease, Pulmonary Hypertension Association Says
8. Physician Groups Call for Fewer Medical Tests
9. From herd immunity and complacency to group panic: How vaccine scares unfold
10. Study finds significant skull differences between closely linked groups
11. Diabetes Groups Issue New Guidelines on Blood Sugar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: